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1062Objective: Reoperative sternotomy to address mitral valve pathology carries substantial risk, especially with
patent bypass grafts or an aortic valve prosthesis. We previously reported our early experience with minimally
invasive right thoracotomy and peripheral cannulation as an alternative strategy, and we recently reviewed our
cumulative 15-year hospital outcomes with this approach.
Methods: Between June 1996 and April 2010, we performed right minithoracotomy for reoperations involving
the mitral valve on 167 patients, 85 (51%) of these since 2006. Seventy-one percent had undergone
previous coronary artery bypass grafting and 38% a previous valve procedure. Fibrillatory arrest was used in
77% and aortic clamping and root cardioplegia in 23%. Nineteen procedures were performed with robotic
assistance.
Results: Mitral repair frequency increased during each 5-year interval of our experience (1996–2000, 43%;
2001–2005, 53%; 2006–2010, 72%; P ¼ .019), including 80% of native mitral valves without stenosis. Con-
comitant procedure frequency, most commonly atrial fibrillation ablation, also increased during each 5-year in-
terval (0%, 21%, 48%; P<.0001). Thirty-day mortality was 3.0% (5/167), 0% since 2005. There were no
conversions to sternotomy or aortic dissections. Stroke, in 2.4% (4/167), was statistically unrelated to fibrilla-
tory arrest. Increased New York Heart Association functional class (odds ratio, 5.6; 95% confidence interval
1.1–27.8; P ¼ .037) was the only independent predictor of mortality in multivariable analysis.
Conclusions: Our updated experience confirmed the effectiveness of minimally invasive right thoracotomy
to treat mitral pathology while avoiding reoperative sternotomy risk. We found fibrillatory and cardioplegic ar-
rest methods to be safe myocardial preservation strategies with this approach. (J Thorac Cardiovasc Surg
2012;143:1062-8)Although the principal interest in minimally invasive mitral
valve approaches has been among patients undergoing elec-
tive operations in the primary setting, the avoidance of re-
operative sternotomy may represent a more compelling
indication for patients with previous cardiac operations. Re-
operative sternotomy risks injury to patent coronary artery
bypass grafts and right-sided cardiac chambers, particularly
in patients with pulmonary hypertension. In addition, a pre-
existing aortic valve prosthesis may hamper mitral exposure
when approached through a sternotomy.
These risks are substantial but are rarely quantified, with
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The Journal of Thoracic and Cardiovascular Surpathology focusing purely on reoperations after previousmi-
tral repair or replacement.1-8 The report of Lytle and
colleagues9 stands alone as having reviewed all reoperations
involving a valve and demonstrated that a previous aortic
valve replacement was the most pronounced risk factor
when approaching native or prosthetic mitral disease, carry-
ing amortality of 26%. Likewise, specifically addressing pa-
tientswith previous coronary artery bypass grafting (CABG)
who required native or prosthetic mitral operations, Izhar
and associates10 and Jamieson and coworkers11 identified
operative risks of 8.8% and 14%, respectively. Although
the Society of Thoracic Surgeons (STS) risk calculator12
suggests a lower risk than these series, the nonoperative
treatment of patients deemed to carry excessive risk suggests
that the computed risk likely represents an underestimate.
Since 1996, we have recognized this challenging sce-
nario as an appropriate direction for a minimally invasive
approach. In 2004, we reported on a 38-patient retrospective
experience with a 5-cm right anterior thoracotomy to ap-
proach the mitral valve after previous cardiac operations.13
We compared this cohort with 33 patients undergoing re-
operative sternotomy and demonstrated a lower red blood
cell transfusion rate, shorter intubation duration, and
a shorter postoperative stay with the minimally invasive ap-
proach. Mitral repair was performed in only 42% ofgery c May 2012
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
NYHA ¼ New York Heart Association
STS ¼ Society of Thoracic Surgeons
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Dpatients. The operative mortality was 5.7%, similar to that
reported in a larger series by the Leipzig group.14 Because
our minimally invasivemitral experience has matured to en-
compass more than 1000 cases, we evaluated the success of
this approach in an updated series of reoperative patients.MATERIALS AND METHODS
The study was approved by the institutional review board, and the re-
quirement for individual patient consent was waived. The hospital records
of all cardiac surgical patients at our center have been abstracted in a data-
base for STS reporting. This database was queried for all patients undergo-
ing minimally invasive mitral valve procedures as cardiac reoperations,
beginning with the first patient in 1996. Patients were excluded if the
only previous cardiac operation was a coarctation procedure performed
through a left thoracotomy or a pericardial drainage procedure. Current op-
erations performed through a partial sternotomy were excluded. Primary or
reoperative mitral repair or replacement procedures were included,
whether performed singly or in combination with tricuspid repair or re-
placement, atrial septal defect closure, or atrial fibrillation ablation. There
were no exclusions for enhanced surgical acuity. Among more than 1000
patients undergoing minimally invasive mitral valve operations between
June 1996 and April 2010, a total of 167 patients met these criteria.
Preoperative Characteristics
During the 15-year study period, 14 procedures (8%) were performed
between 1996 and 2000, 68 (41%) between 2001 and 2005, and 85
(51%) between 2006 and 2010 (Figure 1, A). The preoperative character-
istics are listed in Table 1. The age of patients ranged from 35 to 86 years,
with 45% of patients 70 years old or older. Eighty-eight percent of patients
had undergone 1 previous cardiac operation, most frequently (71%) in-
volving CABG. A previous aortic, mitral, or tricuspid valve procedure
had been performed in 64 patients (38%).
Elective operations were performed in 90.4% of patients. The mean
New York Heart Association (NYHA) functional class was 2.6  0.8,
with 54% of patients in NYHA class III or IV. The left ventricular ejection
fraction was 49%  12%; 20 patients (12%) had an ejection fraction of
35% or less. Mitral regurgitation was moderate to severe in 95%. Thirteen
patients had bioprosthetic mitral stenosis (11 with previous mitral repairs),
and 7 had native mitral stenosis. Fifty-four patients had moderate or severe
tricuspid regurgitation.
Surgical Technique
The fundamental technique for minimally invasive mitral valve proce-
dures performed as reoperations has been described previously.13 Opera-
tions were performed with Swan-Ganz catheterization and continuous
transesophageal echocardiographic monitoring; 3-dimensional echocardi-
ography has been used since 2008. After percutaneous insertion of a supe-
rior vena caval cannula through the right internal jugular vein, patients
were positioned supine with the right side of the chest elevated 30. Previ-
ous right thoracotomy was deemed a contraindication to a minimally inva-
sivemitral approach. A 5-cm anterolateral right minithoracotomy in the 4th
intercostal space provided working access, and a separate access port was
used to introduce a videoscope (Olympus Surgical, Center Valley, Pa).The Journal of Thoracic and CarSpecialized elongated-shaft instruments were used (Geister, Inc, Plymouth,
Mass). The da Vinci S system (Intuitive Surgical, Inc, Sunnyvale, Calif)
was used for robotic procedures, with right and left instrument arms placed
in 3rd and 5th intercostal space ports and a left atrial retractor through an
anterior 3rd or 4th intercostal space port. When aortic clamping was per-
formed, a Chitwood transthoracic aortic clamp (Scanlan International,
Inc, St Paul, Minn) was placed posterior to the midaxillary line in the
2nd or 3rd intercostal space. The chest cavity was flooded with carbon di-
oxide to mitigate intracavitary air. Cannulation for cardiopulmonary by-
pass was performed through a 2- to 3-cm oblique infrainguinal incision.
In patients with severe descending aortic or iliofemoral atherosclerosis,
the right axillary artery was cannulated. Vacuum-assisted venous drainage
was used during cardiopulmonary bypass, with systemic cooling to 28C.
Hypothermic (26C) fibrillatory arrest, when used, was induced and main-
tained with a fibrillator or, more recently, a pacing Swan-Ganz catheter
(Edwards Lifesciences LLC, Irvine, Calif). Alternatively, antegrade cardi-
oplegia was delivered through a transthoracic catheter. Retrograde cardio-
plegia was infrequently used.
Standard mitral repair and replacement techniques were used. Annulo-
plasty rings (Simulus FLX-C; ATS Medical, Inc, Minneapolis, Minn;
Cosgrove-Edwards Annuloplasty System; Edwards Lifesciences) were se-
cured with 2-0 Cardioflon suture (Peters Surgical, Bobigny, France) or ni-
tinol clips (Coalescent Surgical, Inc, Sunnyvale, Calif). Mitral replacement
was performed with posterior leaflet sparing. Deairing was accomplished
with Valsalva maneuvers and volume filling of the heart, through a transmi-
tral vent frustrator catheter that exited through the atriotomy closure and,
when feasible, through an aortic root vent. In patients undergoing concom-
itant tricuspid repair, a transseptal approach was used for mitral valve ex-
posure. Linear ablation for atrial fibrillation was performed in most patients
with cryothermy (CryoMaze; ATS Medical). We have preferred a biatrial
lesion set for long-standing persistent and permanent atrial fibrillation.
Statistical Methods
Preoperative characteristics, intraoperative data, and postoperative out-
come variables were recordedwith STSDatabase definitions.15 Continuous
variables were expressed as mean SD.We performed univariate analyses
of 13 preoperative and intraoperative risk factors for mortality, including
age, sex, surgical urgency, 5-year surgical experience interval, number of
previous operations, NYHA functional class, mitral pathophysiology, mi-
tral procedure, concomitant procedure, myocardial preservation method,
and intervals of fibrillatory and cardioplegic arrest and cardiopulmonary
bypass. These analyses were performed with unpaired Student t tests, c2
tests, or Fisher Exact tests, as appropriate. Means tested over intervals of
surgical experience were compared with analysis of variance (SAS version
9.2; SAS Institute Inc, Cary, NC).Multivariable log-normal plots were used
to assess underlying normality and heteroskedasticity of the data.When ap-
propriate, normalizing or variance stabilizing transformations were applied
to the data. Model lack of fit for multivariable logistic regression analyses
was assessed with the Hosmer-Lemeshow procedure, which compares ob-
served and expected event rates in subgroups of the model population.
RESULTS
Among the 167 patients, 103 (62%) underwent mitral
valve repair. The frequency of repair increased during
each 5-year interval (1996–2000, 43%; 2001–2005, 53%;
2006–2010, 72%; P ¼ .019); this and additional interval
trends are depicted in Figure 1 (B through E). Repair proce-
dures involved annuloplasty alone in 60 patients. Isolated
annuloplasty repairs were more frequent than more com-
plex repairs among patients whose previous operation in-
volved CABG (92% vs 67%; P ¼ .0018). Complex
repairs, including leaflet and chordal procedures, werediovascular Surgery c Volume 143, Number 5 1063
FIGURE 1. Fifteen-year trends in minimally invasive reoperations in-
volving the mitral valve by 5-year interval. A, Procedure volume increased
by interval, with 51% of procedures performed in the last 5 years. B, Fre-
quency of mitral valve repair increased by interval, to 72% in the last 5
years. C, Frequency of procedures (atrial fibrillation ablation, tricuspid
valve repair or replacement, atrial septal defect or patent foramen ovale clo-
sure) combined with mitral valve operation increased by interval, to 48%
in the last 5 years. D, Fibrillatory arrest (26C) was more commonly used
than aortic clamping and cardioplegia in each interval, an increasing trend.
E, Trend toward decreasing 30-day mortality by interval, with no deaths
within 30 days in the last 5 years.
TABLE 1. Preoperative characteristics (n ¼ 167)
Age (y, mean  SD) 66.9  10.7
Age 70 y 75 (45%)
Sex (male) 103 (62%)
Previous operations
1 147 (88%)
2 19 (11.4%)
3 1 (0.6%)
Previous operations (type)
Isolated CABG 94 (56%)
CABG and valve 24 (14%)
Aortic valve replacement 19 (11%)
MV repair 34 (20%)
MV replacement 7 (4%)
Surgical timing
Elective 155 (93%)
Urgent 10 (6%)
Emergency 2 (1.2%)
NYHA functional class (mean  SD) 2.6  0.8
NYHA class IV 23 (14%)
Ejection fraction (%, mean  SD) 49  12
Mitral regurgitation
Moderate 21 (12%)
Severe 138 (83%)
Mitral stenosis 20 (12%)
Tricuspid regurgitation
Moderate 35 (24%)
Severe 19 (13%)
All data represent numbers of patients unless indicated otherwise. CABG, Coronary
artery bypass grafting; MV, mitral valve; NYHA, New York Heart Association.
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patient. The mean annuloplasty ring diameter was 31  3
mm; the ring diameter was smaller for isolated annuloplasty
repairs (29 2 mm vs 33 4 mm, P<.0001). Mitral recon-
struction did not involve annuloplasty in 3 patients.
Mitral replacement was performed in 64 patients, and in
33 (52%) of these cases a bioprosthesis was implanted. The
mean labeled valve size was 27  2 mm. Replacement was
performed for 25% of native valves and for 75% of patients
with a previous mitral procedure. Procedures in native and
previously operated mitral valves are outlined in Table 2.
Robotic assistance with the da Vinci system was used in
19 of the 167 mitral procedures (11.4%). This included 4
isolated annuloplasty repairs, 10 complex repairs, and 5 re-
placements. All but 1 of the robotic procedures was per-
formed in the most recent 5-year interval.1064 The Journal of Thoracic and Cardiovascular SurTricuspid repair was combined with mitral repair in 5 pa-
tients and with mitral replacement in 4. Concomitant mitral
and tricuspid replacement was performed in 1 patient.
Forty-five patients (27%) underwent concomitant cryo-
ablation, radiofrequency, or microwave ablation for atrial fi-
brillation. Closure of an atrial septal defect or patent
foramen ovale was performed in 6 patients. The frequency
of combined procedures increased during each successive
5-year interval (1996–2000, 0%; 2001–2005, 21%;
2006–2010, 48%; P<.0001).
Myocardial Protection
Fibrillatory arrest at 26C was used for myocardial pres-
ervation in 129 patients (77%). Aortic occlusion and cardi-
oplegic arrest was used in 39 patients (23%), with
a transthoracic clamp placed in all but 1 patient. Both
methods were required in 1 patient. An interval of hypother-
mic circulatory arrest, with a median duration of 5 minutes,
was required in 6 patients because of aortic valve regurgita-
tion. Fibrillatory arrest was used significantly more often
than cardioplegic arrest among 118 patients who had previ-
ously undergone CABG (90% vs 10%; P<.0001) but not
among 19 who had previous aortic valve replacement (63%
vs 37%; P¼ .120). There has been a trend toward increased
use of fibrillatory arrest in recent years, involving 84% ofgery c May 2012
TABLE 2. Native versus previously operated mitral valves (n ¼ 167)
Native mitral valve 126
Repair procedure 95 (75%)
Annuloplasty only 59
Complex repair 35
Papillary muscle repair 1
Postoperative mitral regurgitation
None or trace 87
Mild 8
Replacement indication 31 (25%)
Mitral regurgitation 24
Mitral stenosis 7
Previous mitral repair 34
Repeat repair procedure 7 (21%)
Annuloplasty only 1
Complex repair 6
Postoperative mitral regurgitation
None 6
Mild 1
Replacement 27 (79%)
Previous mitral replacement 7
Repair paravalvular leak 1
Repeat replacement 6
All data represent numbers of patients.
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significance relative to previous intervals (P ¼ .107).
The mean fibrillatory arrest and crossclamp times were
110  42 minutes and 113  32 minutes (ranges, 39–284
and 36–170 minutes), respectively, and neither the mean fi-
brillatory arrest nor the mean crossclamp time changed sig-
nificantly during each 5-year interval. Among 63 patients
undergoing isolated mitral repair, fibrillatory arrest (52 pa-
tients) and cardioplegic arrest (11 patients) times were sim-
ilar (93  33 minutes vs 105  29 minutes; P ¼ .259). The
mean duration of cardiopulmonary bypass was 167  51
minutes (range, 78–371 minutes).
Complications
There were no aortic dissections or conversions to me-
dian sternotomy. One patient required resumption of cardio-
pulmonary bypass for successful control of bleeding from
an antegrade cardioplegia cannulation site. An intra-aortic
balloon pump was inserted intraoperatively in 3 patients.
Five patients (3.0%) died within the 30-day postoperative
period; however, we have not observed any 30-day postop-
erativemortality within the past 5 years. The causes of death
were cardiac failure in 1 patient, respiratory failure in 2 (1
with pulmonary hemorrhage), cerebrovascular accident in
1, and multisystem organ failure in 1. Major postoperative
complications occurred among 17 of the surviving patients
(10.1%), including reoperation for bleeding in 5 patients,
stroke in 3, respiratory failure in 9, and renal failure in 6
(with 5 requiring dialysis).
There was no relationship on univariate analyses between
the cerebrovascular accidents in 4 patients (2.4%) and useThe Journal of Thoracic and Carof fibrillatory or cardioplegic arrest, age, NYHA functional
class, surgical urgency, a previous valve procedure, previ-
ous CABG, duration of perfusion, or a concomitant proce-
dure. Eighteen patients had pneumonia develop, with 5 of
these occurrences in the right lung. Univariate analyses
showed no association between pneumonia and age,
NYHA functional class, robotic assistance, or a concomitant
procedure. One patient acquired a localized infection at the
thoracotomy wound. Sixty-four patients (38%) received no
transfusions. Among transfused patients, the mean quantity
of packed red blood cells received was 2.9  3.9 units
(median 2.0 units). The median duration of ventilator
support was 11.4 hours, and the median postoperative stay
was 6.0 days.
Predictors of Mortality
Thirty-day mortality was associated with increased
NYHA functional class (3.4  0.9 vs 2.6  0.8;
P ¼ .027). Among 23 patients in NYHA class IV, the oper-
ative mortality was 13.7%. Mortality was not related to
ejection fraction, nonelective status, or myocardial preser-
vation method. Lower mortality, with the trend approaching
statistical significance, was observed in each successive in-
terval of experience (1996–2000, 7.1%; 2001–2005, 5.8%;
2006–2010, 0%; P ¼ .069). Only NYHA functional class
was identified as an independent predictor of mortality
with multivariable logistic regression (odds ratio, 5.6;
95% confidence interval, 1.1–27.8; P ¼ .037).
DISCUSSION
The optimal approach to the mitral valve in patients with
a previous sternotomy is controversial, particularly for pa-
tients not requiring concomitant CABG or aortic valve re-
placement. The advantage of a right thoracotomy of
varying size relative to reoperative sternotomy has been
avoidance of injury related to sternal reentry or dissection.
Svensson and associates,16 however, in a review of a Cleve-
land Clinic experience, compared 2444 reoperative sternot-
omy cases with 80 right thoracotomy cases and noted
equivalent mortalities of 6.7% and 6.3%, respectively, for
the approaches. Additionally, in their series, a right thora-
cotomy approach was less likely to achieve a mitral repair
and carried a 7.5% cerebrovascular accident rate.
Our report reflects the maturation of an effort beginning
in 1996 to decrease the morbidity of a right thoracotomy
without compromising the intent to repair suitable mitral
valve pathology. In our initial report13 extending to the mid-
dle of 2003, mortality was 5.7% with video-assisted right
minithoracotomy, but replacements outnumbered repairs.
The additional experience since that report, provided by
our primary mitral repair population, has contributed to
the progress of patients undergoing reoperative procedures.
Our 30-day mortality for the cumulative series has been
3.0%, with no deaths within 30 days occurring in the pastdiovascular Surgery c Volume 143, Number 5 1065
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and 72% during the past 5 years.
The success of our minimally invasive strategy hinges on
its effectiveness in addressing both native and previously
operated mitral valves.When approaching a native valve af-
ter previous sternotomy, the distinction between a primary
minimally invasive approach is exposure; once obtained,
the goal of achieving repair whenever feasible is the same
as during a primary operation. In this series, mitral repair
was performed on 75% of all native valves, and among
all native valves without mitral stenosis the repair rate
was 80% (95/119). In 62% of patients (92% of whom
had previous CABG), repair involved annuloplasty alone,
but leaflet repairs and an isolated papillary muscle reim-
plantation were performed in the remainder.
There is greater complexity at multiple sequences in pa-
tients with a previous mitral valve procedure, including the
need to resect prosthetic material. A reoperative repair was
able to be performed in 21% of 34 patients with previous
mitral repair, similar to the outcome in all-cause reoperative
median sternotomy reports.17,18 The minimally invasive
approach did not impede the smaller number of repeated
mitral replacements, with bioprostheses in most cases,
and repair of a paravalvular leak in 1 patient. Although
our experience has shown the minimally invasive
approach to be effective and safe, our relatively infrequent
and only recent adoption of da Vinci robotic assistance in
the latest 5-year interval reflects a learning curve and under-
scores the greater complexity of reoperative procedures rel-
ative to primary procedures.
Another important distinction between primary and re-
operative procedures during our 15-year experience has
been an evolution in myocardial preservation strategy.
One advantage of the right minithoracotomy approach is
the avoidance of extensive dissection, and the use of hypo-
thermic fibrillatory arrest circumvents the need for place-
ment of a transthoracic clamp and cardioplegia delivery,
especially with functional proximal coronary anastomoses.
Our deairing strategy, primarily with a transmitral vent
catheter exiting through the left atriotomy closure, has
been effective in minimizing cerebrovascular morbidity.
In our series, the use of fibrillatory arrest in reoperative
patients increased from 67% to 82% during the last
decade, a trend that approached statistical significance.
The choice of myocardial preservation did not affect mor-
tality in our series, which compares favorably with other
reports.14,19 Fibrillatory arrest has been used with
a similar frequency in Leipzig14 and has been the pre-
ferred approach for primary and reoperative patients at
Vanderbilt University.20,21 Although another option,
endoaortic balloon occlusion and cardioplegic arrest, has
been favored by several groups,19,22,23 the simplicity and
the reliability of myocardial preservation with fibrillatory
arrest have reinforced its use in our practice.1066 The Journal of Thoracic and Cardiovascular SurThe safety of fibrillatory arrest in our reoperative experi-
ence contrasts sharplywith the findings from a STSDatabase
series24 of a 6-fold increase in stroke when using fibrillatory
arrest with minimally invasive mitral repair. This specific
finding notwithstanding, avoiding complications related to
retrograde aortic perfusion and neurologicmorbidity, includ-
ing aortic dissection and atheroembolism, is paramount in
the reoperative setting. No patients in our series sustained
an aortic dissection. Moreover, with widespread adaptation
to 17F to 19F femoral arterial cannulas, preoperative vascu-
lar screening, and strict transesophageal echocardiographic
insertion guidance, aortic injury has occurred in 0.0% to
0.9% in comparable reoperative series.14,19,20,22,23 Our
practice has been to screen selectively patients with
a history of peripheral vascular disease, and we have
extended such screening to elderly patients in recent years.
Stroke as a complication has been more reproducibly
linked to retrograde arterial perfusion than to fibrillatory ar-
rest in patients undergoing reoperative mitral valve proce-
dures. Investigators at New York University25 identified
retrograde perfusion as an independent risk factor for stroke,
with an incidence of 10.9% versus 3.0%with central aortic
cannulation and antegrade perfusion, their preferred strat-
egy. Stroke was also roughly 3 times more frequent in the
Cleveland Clinic series16 when using a right thoracotomy
approach and retrograde femoral perfusion. The 2.4% inci-
dence of permanent stroke in our series not only was statis-
tically unrelated to our choice of fibrillatory arrest for
myocardial preservation but also was within the 0.9%
to 5.8% range observed in other minimally invasive reoper-
ative reports14,19,21-23 and comparable with the 2.7%
rate observed among patients undergoing reoperative
sternotomy in the Cleveland Clinic experience.16 Axillary
artery cannulationwas used in 5.4% of patients in our series,
and we concur with the practice at Vanderbilt20,21 of setting
a low threshold for axillary cannulation for perfusion in
patients with aortic atherosclerosis.
In addition to growth in procedural volume, a measure of
our evolving confidence with the minimally invasive ap-
proach has been the performance of combined procedures
in patients undergoing reoperation. Concomitant tricuspid
repair, the maze procedure, and atrial septal defect closure
have increased substantially during each 5-year interval of
our experience (P< .0001) to encompass 48% of proce-
dures since 2006. The range of concomitant procedures in
patients undergoing reoperation is limited relative to that af-
forded with transsternal exposure but is comparable to that
achieved with a right minithoracotomy in primary opera-
tions. It is notable that our concomitant performance of
the maze procedure in 26% of patients was equivalent in
frequency to another recent reoperative minimally invasive
mitral series from Leipzig.14 Given the broader access
through a reoperative sternotomy, the increased rate at
which a combined mitral–maze procedure appears to havegery c May 2012
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somewhat paradoxic. One explanation for this disparity
may be the enhanced interest in recent years in addressing
coexisting atrial fibrillation. It is alternatively plausible
that exposure for an endocardial ablation strategy is more
facile through a lateral thoracotomy approach than is ad-
dressing the dissection required for either epicardial or en-
docardial approaches through a reoperative sternotomy.
Although we did not compare reoperative sternotomy
and right minithoracotomy in this study, the only risk factor
for mortality that manifested in the analyses, increased
NYHA congestive heart failure class, has been seen with
standard cardiac operations. Other variables particular to
the minimally invasive approach, notably fibrillatory arrest,
did not emerge as risk factors. Although these findings are
not definitive, such a pattern suggests equivalent successes
at our center of the minimally invasive approach and reoper-
ative sternotomy.
Among nonfatal complications, however, we observed
a 10.8% frequency of postoperative pneumonia. Twenty-
eight percent of these pneumonias were localized to the
right lung and likely represent a complication specific to
the minimally invasive approach. We are uncertain of the
mechanism, aside from speculation regarding subtle
trauma, but we note that an 8.8% rate of pneumonia or re-
spiratory failure in reoperative minimally invasive cases has
been observed by Casselman and colleagues.22
We demonstrated improved recovery parameters in our
2004 report13 with minimally invasive mitral reoperations
relative to reoperative sternotomy. That analysis, unlike
our updated series, excluded patients with more than 1 pre-
vious operation, emergency status, or combined procedures.
Our cumulative 15-year experience demonstrated sustained
favorable outcomes with our 2004 report in median ventila-
tion time (11.4 vs 11.4 hours, respectively) and mean red
blood cell transfusions (2.9 vs 2.9 units), with a modest im-
pact in median postoperative hospital stay (6.0 vs 5.0 days)
despite an increase in procedural complexity. The number
of red blood cell transfusions and the ability to avoid trans-
fusion in 38% of patients were observations similar to the
Vanderbilt reoperative experience.21
The general interpretation of our updated experience, un-
like the 2004 report, is limited in part by the absence of a de-
fined reference group. In addition, our 15-year report
describes an evolving technique, and this evolution likely
entailed patient selection for a minimally invasive ap-
proach, as well as the choice of myocardial preservation
and the inclusion of concomitant procedures.
In summary, our 15-year experience has demonstrated
the utility of minimally invasive right thoracotomy to effec-
tively address mitral valve pathology in reoperative patients
while avoiding the risk of a repeat sternal reentry. Although
this technique has been applied with increasing frequency
as well as to greater patient complexity at our center, theThe Journal of Thoracic and Carassociated mortality has decreased with time and appears
favorable relative to historical studies involving reoperative
sternotomy. Our expanded series confirms both fibrillatory
and cardioplegic arrest to be useful preservation strategies,
and minimally invasive right thoracotomy has supplanted
sternotomy as our preferred approach to correct mitral re-
gurgitation in the reoperative setting.
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